📰 Aadi Bioscience News
Page 9 - Aadi Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aadi Bioscience. Real-time updates on events, politics, business and more.
April 7, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,336 shares of the stock in a transaction dated Wednesday, April 5th. The shares were sold at an average price of $7.24, for a total transaction of $53,112.64. Following the completion of the transaction, the chairman now directly owns 1,885,755 shares in the company, […]
April 6, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,336 shares of the stock in a transaction on Wednesday, April 5th. The stock was sold at an average price of $7.24, for a total value of $53,112.64. Following the completion of the sale, the chairman now directly owns 1,885,755 shares in the company, […]
April 6, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...
April 1, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,450,000 shares, an increase of 22.9% from the February 28th total of 1,180,000 shares. Based on an average daily volume of 119,800 shares, the days-to-cover ratio is presently 12.1 days. […]
April 1, 2023
Aadi Bioscience (NASDAQ:AADI – Get Rating) had its price objective reduced by HC Wainwright from $48.00 to $45.00 in a research report released on Wednesday morning, The Fly reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Aadi Bioscience’s Q1 2023 earnings at ($0.61) EPS, Q2 2023 earnings […]
March 31, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 1,450,000 shares, a growth of 22.9% from the February 28th total of 1,180,000 shares. Currently, 9.0% of the shares of the stock are sold short. Based on […]
March 30, 2023
Operator: Good day and thank you for standing by. Welcome to the Aadi Bioscience Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
March 28, 2023
Real-time index price for TSX Real Estate Capped Index (TTRE), along with buy or sell indicators, analysis, charts, historical performance, news and more
March 28, 2023
Forward-Looking Statements Certain statements contained in this presentation regarding matters that are not historical facts, are forward-looking statements... | March 28, 2023
March 27, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...